#39;The Applicant #39; - Schulich Medicine Admissions Video 2013
Admissions video for Interview Weekend 2013 created by the Class of 2016 at the Schulich School of Medicine and Dentistry at Western University of Canada. ht...
By: UWOMedAdmissions
Continue reading here:
'The Applicant' - Schulich Medicine Admissions Video 2013 - Video
NOKOMIS, Fla.--(BUSINESS WIRE)--
As Rainbow Coral Corp.s (RBCC) biotech subsidiary, Rainbow BioSciences, seeks out potentially lucrative new opportunities in the $232 billion personalized medicine market, the company announced today that it will target new innovations in the growing field of companion diagnostics.
The personalized medicine market in the U.S. is ripe for expansion, with PricewaterhouseCoopers predicting that the sector could grow to as much as $452 billion by 2015. One of the fastest-growing fields in the market is companion diagnostics, which could grow to as large as $42 billion by 2015, according to industry analysts TriMarkPublications.com.
The key to that growth will be innovation. Companion diagnostics is the use of genetic variation to chart different patient responses to specific drugs or biologic agents in order to create effective, efficient treatments tailored to a patients genetic profile. The emerging field is believed by many medical experts to have an increasingly important role to play in cancer treatments in coming years.
Companion diagnostics represent the very cutting edge of technology in medicine today, said RBCC CEO Patrick Brown. We believe the key to our success is bringing desperately needed new innovations to the market that will improve patient outcomes and reduce healthcare costs. Companion diagnostics offer us the best opportunities to achieve that goal.
For more information on Rainbow BioSciences personalized medicine initiatives, please visitwww.rainbowbiosciences.com/investors.html.
Rainbow BioSciences will develop new medical and research technology innovations to compete alongside companies such as Bristol Myers Squibb Co. (NYSE:BMY),Biogen Idec Inc. (NASDAQ:BIIB), Abbott Laboratories (NYSE:ABT) and Amgen Inc. (NASDAQ:AMGN).
About Rainbow BioSciences
Rainbow BioSciences, LLC, is a wholly owned subsidiary of Rainbow Coral Corp. (OTCBB:RBCC). The Company continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. For more information on our growth-oriented business initiatives, please visitwww.RainbowBioSciences.com. For investment information and performance data on the Company, please visitwww.RainbowBioSciences.com/investors.html.
Notice Regarding Forward-Looking Statements
Continue reading here:
A new law set to take effect in Medicine Hat will ban smoking in outdoor public places just in time for summer.
The law, spearheaded by local high school students, restricts smoking within 10 metres of public fields, paths, playgrounds and beaches.
"It's about trying to find that balance where non-smokers' rights can be honoured but also recognizing that smoking isn't illegal," says Varley Weisman, manager of social development with the city of Medicine Hat.
More than 50 municipalities across Canada already have similar bylaws in place, including Edmonton, Grande Prairie and Red Deer. Calgary does not.
"There's nothing worse than inhaling second-hand cigarette smoke, while being active," says Medicine Hat's Youth Advisory Chair Austin Desharnais. "Smokers have the right to smoke but saying that, we feel it's also important that non-smokers have the rights too."
Some say that the new law goes too far.
"I think they should be allowed to smoke," says local resident Logan Krastel. "We're outside like, you know, they have rights too."
Medicine Hat will be putting up signs in the next few weeks and spreading the word about its new rule.
The new law will take effect in the coming months and will carry a $100 fine for infractions.
A motion on smoking in outdoor areas where children are allowed is going to committee in Calgary next month.
Here is the original post:
Running water, electricity, and paved roads are hard to find in the remotest parts of sub-Saharan Africa. A bottle of warm Coca-Cola, though? No sweat. This impressive reach isnt lost on public health advocates. They are looking to Cokes distribution network to bring cheap, life-saving medication to some of the worlds most remote places.
Since September, more than 40,000 medicine kits designed to slip between Coke bottles stacked in a case have made the journey deep into the Zambian countryside. Called Kit Yamoyo, the packets were designed by London branding agency pi global for the U.K.-based health charity called ColaLife to fight one of sub-Saharan Africas biggest child killers, diarrhea. The kits, priced at the equivalent of $1, carry vital antidiarrheal medicinea blister pack of zinc pills, oral rehydration saltsin a container that doubles as a mixing vessel. (The kit also carries a thin bar of soap.)
Instead of a mother having to travel three, sometimes four hours to a regional health center, she can now go to the community shop where they usually find Coca-Cola for sale, says Rohit Ramchandani, public health adviser and principal investigator for ColaLife. Our model looks specifically at how we can partner with and leverage private sector distribution channels, these companies that are able to get their product out to that last mile in the most remote parts of the world. In the future, ColaLife plans to use the same container design to transport safe-birthing kits, mosquito nets, and nutrient supplements, Ramchandani says.
Pi globals product designa heat-sealed, water-resistant, tamper-proof plastic kit that looks as if it could hold a wedge-shaped vending machine sandwichallows 10 kits to be slipped inside a single crate of Coca-Cola. In this part of the world, it also represents the first all-in-one, single-dose antidiarrheal kit.
Cokes involvement in the project has been easier to measure in crates than in dollars. We didnt ask Coca-Cola and their bottler SABMiller to fund the Zambia trial directly, says Jane Berry, ColaLifes business development director. We wanted it to be independentcreating evidence and learning [that] people could trust. What we wanted was permission to piggyback on their knowledge, brand, expertise, methods, and networks, which they have very generously given.
Read this article:
DUBLIN--(BUSINESS WIRE)--
Research and Markets has announced the addition of the "European Nuclear Medicine / Radiopharmaceuticals Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & Stable Isotopes (Deuterium, C-13) - Global Trends & Forecas" report to their offering.
The European radioisotopes market was valued at $1.1 billion in 2012 and is poised to reach $1.6 billion in 2017 at a CAGR of 6.8%.
A study conducted by Organization for Economic Co-operation and Development (OECD) estimates that Tc-99m diagnostic procedures are expected to increase by 15% to 20% in mature markets such as Europe, and other developed regions between 2010 and 2030. Radiopharmaceuticals in neurological applications such as Alzheimer's disease, Parkinson's disease, and dementia are also being preferred by practitioners besides conventional treatment. Further, upcoming radioisotopes such as Ra-223 (Alpharadin) and Ga-68 possess huge potential for clinical applications. The scheduled shutdown of the NRU reactor in 2016 and OSIRIS in France in 2018 is, however, a major threat for manufacturers.
The therapy market is predominantly driven by its oncologic applications. Since conventional treatment procedures of cancer, surgery and chemotherapy have significant side effects, radioisotopes are being preferred by medical practitioners due to minimum or no side effects. The radiopharmaceutical therapy market is expected to grow significantly with the launch of the much-desired Alpharadin (Ra-223) in the near future. This isotope has tremendous potential to take up market share of beta emitters and brachytherapy.
The radioisotope and stable isotope markets have been segmented according to the type of isotope, and applications. Both of these markets are broken down into segments and sub-segments, providing exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2017. Each market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the European scenario.
Key Topics Covered:
1 Key Take-Aways
2 Executive Summary
3 Market Overview
Original post:
WILMINGTON, Delaware, April 9, 2013 /PRNewswire/ --
With the Family Physicians revenue cycle management in a state of transition due to the upcoming Affordable Care Act (ACA), Medicalbillersandcoders.com has witnessed a large demand from Family Medicine practice centers across the US keen on outsourcing their billing functions to MBC in order to enhance their RCM.
The ACO impact on Family practice billing and coding
The impact Accountable Care Organizations (ACO) will have on these practices explains the reason behind an increased number of Family practices currently rushing to MBC for their billing solutions.
Though the ACO environment may benefit these practices by promoting primary care hence making it accessible and improving provider reimbursements, it also brings with it many changes as it prompts federal and commercial payers to change the way they make payments. The challenge it provides to Family practice billing and coding is that they would require transitioning their reimbursement models from volume-based to value-based to a higher number of patients with little time left for billing.
MBC's billing and coding experts believe that "Family Physicians within the next five years will need to adopt the new revenue reimbursement models as a result of ACA. Though this may seem simple enough, practitioners will need to work much harder to maximize their revenues."
Identifying resulting revenue transition challenges
MBC understands that in the ACO environment accurate medical coding and billing is vital to maximizing revenue, being aware of the resulting issues they face with this transition, -
How MBC has been guiding Family Medicine Practitioners
Medicalbillerandcoders.com is aware that improved Family Practice revenue cycle management requires in-depth, insider industry expertise of the new coding, billing and compliance regulations. MBC specialists continuously correlate higher practice revenue to timely billing and account reimbursements, offering best billing strategies, models and consultancy and providing guidance in areas like population health management.
Originally posted here:
MBC Guides Family Medicine Practitioners to Effectively Tackle the ACA Impact!
Newswise BOSTON (April 9, 2013) Medical school graduates entering one family medicine residency program might receive training that is markedly different than another family medicine residency program. While these new medical school graduates, called residents, will gain the clinical knowledge needed to practice medicine, their scope of skills depend on their specific experiences as residents. A team of healthcare professionals from the Family Medicine Residency Program at Tufts University School of Medicine have published a paper in the Journal of Graduate Medical Education that suggests a way to evaluate family medicine residents based on their level of competency.
Family medicine resident training is currently determined by the types of patients that the residents treat at their specific hospital or clinic, rather than being determined by the curriculum. We have created a list of entrustable professional activities or EPAs to assess clinical competencies that clearly define the breadth of skills required at the completion of residency, said Allen Shaughnessy, Pharm.D., M.Med.Ed., professor at Tufts University School of Medicine and fellowship director of the Tufts University Family Medicine Residency Program at Cambridge Health Alliance.
Shaughnessy worked with a team of healthcare professionals from Tufts University School of Medicines Family Medicine Residency Program to develop a list of 76 EPAs around which to structure a competency-based assessment of family medicine residents.
Competence is defined as the ability to do something successfully. Defining the list of somethings in family medicine residencies has been difficult for both educators and regulators, said Gregory L. Sawin, M.D., M.P.H., assistant professor at Tufts University School of Medicine and program director, Tufts Family Medicine Residency at Cambridge Health Alliance.
Competency-based medical education ensures that medical residents acquire a certain set of skills, behaviors, and attitudes in addition to the clinical knowledge needed to practice medicine. When these skills, behaviors, and attitudes are integrated and performed in an educational setting, they become known as entrustable professional activities. An activity is entrustable when a supervisor deems that a medical resident could have performed a task without supervision; in this case, the resident has demonstrated competency in a given area. As an example, the authors write:
For example, a competent family medicine physician is expected to provide care for a child with a respiratory illness. This includes eliciting a history, performing a physical examination, arriving at a diagnosis, and implementing a plan of care that is evidence based and takes into account the needs and values of the patient. Although each of these skills can be separately measured and documented in a variety of settings, the overall performance of them in situ constitutes the entrustable activity.
In addition to confirming that family medicine residents know how to treat a specific disease or condition, the EPAs can ensure that residents acquire skills that enable them to effectively interact with medically-diverse patients, uphold ethical principles, use information sources at the point of care, and develop skills relating to running a medical practice.
The leading effort to define competencies is the Outcome Project, from the Accreditation on Graduate Medical Education (ACGME) and the American Board of Medical Specialties. The Outcome Project is shifting medical education from assuring quality through intense training processes to measuring outcomes and specific skill. This shift in medical training was the result of calls for greater accountability in all aspects of the profession.
Shaughnessy notes that the Outcome Project leaves the definition of actual competencies and their assessment to individual residencies. Interpretation may lead to vague competency categories that are not specific enough to provide definitive guidance to residents or faculty members regarding what learning needs to be accomplished and documented. In response, the EPAs provide a detailed, concrete approach to training and evaluating residents in how they provide care.
The initial EPAs presented in the paper were developed at the Tufts University School of Medicine Family Medicine Residency Program, based on the ACGME guidelines, over a two year period. Twenty-one experts were recruited to further determine and refine the EPAs that are most relevant to family medicine education. The experts participated in two rounds of anonymous, internet-based surveys to compile the final list of EPAs. The process began with 91 EPAs that were then narrowed down to 76 based on the feedback.
Read more from the original source:
Defining the Scope of Skills for Family Medicine Residencies
WMMC Internal Medicine --Walking Towards Excellence--
Western Mindanao Medical Center The first and only PCP accredited PRIVATE training hospital in Western Mindanao.
By: Marlon Loquias
Here is the original post:
WMMC Internal Medicine --Walking Towards Excellence-- - Video
Newswise WASHINGTON, D.C. As many as three quarters of advanced ovarian cancer patients appeared to respond to a new two-step immunotherapy approach -- including one patient who achieved complete remission -- according research from the Perelman School of Medicine at the University of Pennsylvania that will be presented today in a press conference at the AACR Annual Meeting 2013 (Presentation #LB-335).
The immunotherapy has two steps a personalized dendritic cell vaccination and adoptive T-cell therapy. The team reports that in the study of 31 patients, vaccination therapy alone showed about a 61 percent clinical benefit, and the combination of both therapies showed about a 75 percent benefit.
The findings offer new hope for the large number of ovarian cancer patients who relapse following treatment. The first step of the immunotherapy approach is to preserve the patients tumor cells alive, using sterile techniques at the time of surgery so they can be used to manufacture a personalized vaccine that teaches the patients own immune system to attack the tumor. Then, the Penn Medicine team isolates immune cells called dendritic cells from patients blood through a process called apheresis, which is similar to the process used for blood donation. Researchers then prepare each patients personalized vaccine by exposing her dendritic cells to the tumor tissue that was collected during surgery.
Because ovarian cancer symptoms can be stealth and easily mistaken for other issues constipation, weight gain, bloating, or more frequent urination more than 60 percent of patients are diagnosed only after the disease has spread to their lymph nodes or other distant sites in the body, when treatment is much less likely to produce a cure compared to when the disease is detected early. As the fifth leading cause of cancer-related deaths among women in the United States, it takes the lives of more than 14,000 women each year.
Given these grim outcomes, there is definitely a vast unmet need for the development of novel, alternate therapies, said lead author Lana Kandalaft, PharmD, PhD, MTR, a research assistant professor of Obstetrics and Gynecology and director of clinical development and operations in Penn Medicines Ovarian Cancer Research Center. This is the first time such a combination immunotherapy approach has been used for patients with ovarian cancer, and we believe the results are leading us toward a completely new way to treat this disease.
Both treatments are given in conjunction with bevacizumab, a drug that controls the blood vessel growth that feeds tumors. Combining bevacizumab with immunotherapy makes a powerful duo, Kandalaft says. The vaccine trial is still open to accrual to test new combinatorial strategies.
The other Penn authors are Janos Tanyi, Cheryl Chiang, Daniel Powell, and George Coukos. This study was funded by a National Cancer Institute Ovarian Specialized Program of Research Excellence grant, the National Institutes of Health and the Ovarian Cancer Immunotherapy Initiative.
Dr. Kandalaft will present the findings of the trial on Saturday, April 6, 2013 in the Late Breaking Clinical Trials press conference at 1:00 p.m. ET in room 153 of the Walter E. Washington Convention Center, 801 Mt Vernon Pl. NW, Washington, DC. She will also present during the Late-Breaking Research: Immunology poster session in Hall A-C (Poster Section 46) on Wednesday, April 10, from 8 a.m. to noon ET.
###
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise. The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 16 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $398 million awarded in the 2012 fiscal year.
The rest is here:
Integrative Medicine - Changing the Healthcare System
RN Barbara Abruzzo discusses her thoughts on holistic and integrative medicine. This is an excerpt clip from episode #47 of The Magical Medical Tour with hos...
By: YogaHub .
The rest is here:
Integrative Medicine - Changing the Healthcare System - Video
Naturopathic Medicine: Homeopathy V.S. Isopathic Remedies
Health care advocate Barbara Abruzzo answers questions and helps to explain the differences between homeopathic vs. isopathic remedies. This is an excerpt cl...
By: YogaHub .
Link:
Naturopathic Medicine: Homeopathy V.S. Isopathic Remedies - Video
Western Medicine vs The Weeds - Melanie St. Ours #IB12
The talk starts with a snapshot of my experience nearly dying from Ulcerative Colitis in 2005 because I was uninsured. Despite the advances in modern medical...
By: ignitebaltimore
Read the original here:
Western Medicine vs The Weeds - Melanie St. Ours #IB12 - Video
Welcome to the Functional Medicine and Wellness Center
http://www.functionalmedicinecenter.com At the Functional Medicine Center we believe in the body #39;s ability to heal itself and that our role is to facilitate that na...
By: Todd Oczkowski
Read the original here:
Welcome to the Functional Medicine and Wellness Center - Video
General Face - Non Surgical Cosmetic Medicine
Its often said you never get a second chance to make a first impression. At VanderVeer Center you will receive a customized plan that takes into account your...
By: TheVanderVeerCenter
View original post here:
Alternative Medicine - Nutrition - Biofeedback with Dr. George Grant
David Grossman host of Keeping it Real talks to Dr. Grant talks about his 35 year #39; Journey from Medical/Pharmaceutical research to Integrative medicine, the ...
By: David Grossman
Here is the original post:
Alternative Medicine - Nutrition - Biofeedback with Dr. George Grant - Video
Pediatric Pain Medicine Program Uses Revolutionary Distract, Measure, Treat Approach to Tackle Pain in Children
Washington, DC (PRWEB) April 03, 2013
The Sheikh Zayed Institute for Pediatric Surgical Innovation at Childrens National Medical Center has opened a new Pain Medicine Care Complex, which aims to eliminate pain in children by addressing each patients pain from every angle. The Pain Medicine Care Complex combines new treatment approaches with sophisticated data collection via novel gaming technology that fully engage young patients and also objectively measures their treatment progress over time.
Through a cost-effective, continuous loop where evidence drives clinical care, and clinical care drives research, Childrens National is advancing pediatric pain medical research to improve the lives of children and reduce health care costs, said Julia Finkel, MD, Lead Principal Investigator of the Sheikh Zayed Institute for Pediatric Surgical Innovation and Vice Chief of the Division of Anesthesiology and Pain Medicine at Childrens National. Using our unique approach Distract, Measure, Treat we can dramatically improve patient outcomes in the short term while simultaneously driving long-term research to transform how care is delivered to children in the United States and around the world.
According to data collected by Childrens National, approximately one in four parents of patients treated at the hospital has to quit their job or reduce working hours to care for a child in pain. Frequently, these patients also are misdiagnosed or treated for another disease, and pain is not acknowledged as a unique diagnosis if not linked to a specific condition. Misdiagnosis, along with uncoordinated, inefficient care and lost work productivity, can drive up the cost of treating pediatric (and adult) pain within the United States healthcare system.
Until now, it has been impossible to quantitatively measure and monitor chronic pain in children, said Sarah Rebstock, MD, PhD, Clinical Director of the Pain Medicine Program and a Principal Investigator of the Sheikh Zayed Institute. Childrens National has developed a promising solution to this problem that applies objective measurement to video gaming therapy that is uniquely designed for pediatrics. The data we collect will enable us to optimize care for each individual patient we treat at the Pain Medicine Care Complex, while also evaluating the success of various treatments over time.
Childrens Nationals pain medicine program is the first of its kind to use unique video gaming therapy, holistic therapeutic tools, and digital data collection to enable short and long-term measurement of patient progress. For the first time, physicians can quantitatively measure pain and assess treatment progress in pediatric patients all within an environment that was specially designed for children and teens. The Complex features the following elements:
A Multi-Sensory Room (MSR) in which a physical therapist uses video gaming therapy that distracts the patient, while simultaneously digitally measuring treatment progress through Kinect technology and a proprietary software application to gather patient data in real-time, which targets and tracks 24 musculoskeletal points in the body.
The Pain Medicine Care Complex is part of the Sheikh Zayed Institute , which launched in 2009. The institute, which aims to make surgery more precise, less invasive, and pain free for children, was made possible by a $150 million gift from the Government of Abu Dhabi to Childrens National Medical Center.
Related Links:
Continued here:
Children’s National Medical Center Unveils New Pain Medicine Care Complex
Individualized Genomic Testing Allows for Tailored Cancer Treatment, New Drug Research
Newswise PHILADELPHIA Just like a massive iceberg jutting out of the ocean, many of cancers genetic underpinnings remain hidden under the surface, impossible to predict or map from above. The foreboding shadows and shapes that appear on CT scans and MRIs and even in the field that doctors see when they zoom in to look at cancer cells under a high-powered microscope are just the tip of the iceberg.
Penn Medicines new Center for Personalized Diagnostics, a joint initiative of the department of Pathology and Laboratory Medicine in the Perelman School of Medicine and the Abramson Cancer Center, is diving deeper into each patients tumor with next generation DNA sequencing. These specialized tests can refine patient diagnoses with greater precision than standard imaging tests and blood work, all with an aim to broaden treatment options and improve their efficacy.
Were using the most advanced diagnostic methods to unlock cancers secrets, says David B. Roth, MD, PhD, chairman of the department of Pathology and Laboratory Medicine. A tumors genomic profile is the most critical piece of information for an oncologist to have when theyre deciding what therapy to recommend. The results of tests in the Center for Personalized Diagnostics reveal a genetic blueprint of each patient's tumor that is as discrete and singular as a fingerprint.
The Center for Personalized Diagnostics unites top experts in genomic analysis, bioinformatics, and cancer genetics who use the most sensitive data analysis tools available to identify the rarest of mutations with oncologists who treat patients and design clinical trials to test new therapies. Together, their efforts will provide cancer patients with cutting-edge diagnostic and therapeutic options.
The first group of patients who are undergoing testing through the CPD includes those with blood cancers and solid tumors of the brain, melanoma, and lung. Throughout 2013, the tests will be expanded for a wider range of cancer patients. Results are available within two weeks twice as fast as most commercially available testing panels. All new and relapsed Abramson Cancer Center patients will receive this testing conducted via simple blood tests and/or biopsy of tumor tissue or bone marrow as part of their evaluation and diagnostic process. Interpretation of results is communicated one-on-one to patients and their caregivers by physicians and genetic counselors.
In contrast to the CPDs offerings, individual genetic tests which now proliferate in the marketplace, even for healthy people who may be interested in going on a spelunking expedition through their DNA are time consuming and expensive to conduct, and they often yield information which is not clinically actionable. When these tests are offered for cancer patients, patients are often left with only a veritable alphabet soup detailing genetic information, with few plans for how to use those findings to conquer their cancer.
Since the CPD began operating in early 2013, however, tests in 80 percent of patients revealed genetic mutations that may be used to alter their treatment course or clarify their prognosis. The results are playing a role in:
Matching patients with existing therapies designed to target mutations previously associated only with different cancers. For instance, some lung cancer patients exhibit mutations of the BRAF gene, which is targeted by drug Vemurafenib, initially developed and approved for melanoma. Testing in the Center for Personalized Diagnostics is helping clinicians make new connections that will expand the indications for existing drugs.
Helping physicians determine which treatments a patient will respond to, or how well they will tolerate a particular treatment. Patients with the blood cancer acute myelogenous leukemia who express a mutation known as DNMT3A, for instance, are known to respond to higher doses of the drug daunorubicin. Learning this type of information prior to beginning treatment can help oncologists select and dose drugs in a way that will reduce side effects and boost patients quality of life during treatment and increase their chance of completing their prescribed regimen.
See original here:
Penn Medicine 's New Center for Personalized Diagnostics Unlocks Cancer's Secrets
LOS ANGELES, April 4, 2013 /PRNewswire/ --The 2013 LA Marathon featured cheering stations scattered throughout the course to inspire thousands of runners to continue to push themselves. However, one cheering station in particular had a charitable goal in mind. In addition to providing music and live performers to the marathoners, the Real Medicine Foundation's cheering station, located at Mile 22, sought to bring awareness to its humanitarian campaign that brings relief to those in disaster and poverty stricken areas around the world. Dr. Payam Jarrah-Nejad, master of cutting-edge plastic surgeries like the Brazilian butt lift and rapid recovery breast augmentation, proudly participated in sponsoring the Real Medicine Foundation's presence at the race.
Dr. J, as his patients and staff affectionately call him, was sadly unable to make an appearance at the marathon. However, he is surely touched by the presence of a banner posted at the mile marker specially thanking him for his contribution. More than that, Dr. J can rest easy knowing he contributed to an important cause that benefits people all over the world. The Real Medicine Foundation spends 92 cents on every dollar towards charitable work that reaches those in need throughout the the United States, South America, Asia, and Africa. Bringing humanitarian support with a keen emphasis on restoring the dignity of people stricken by devastation and extreme poverty, the RMF has donated clothing and supplies around the world, educated locals about important issues like school sanitation and polio vaccinations, invested and trained leaders in many global communities, and much more. The charity's focus is on empowering communities to continue their work once the Real Medicine Foundation has addressed immediate health care needs, including launching programs with an emphasis in indigenous sustainability on subjects like malnutrition eradication, HIV/AIDS care, maternal child healthcare, and Malaria treatment and prevention.
Furthermore, the Real Medicine Foundation benefitted from a group of charitable runners called the Athletes for Real Medicine. This team successfully raised over $10,000 for the Real Medicine Foundation, with many marathoners dedicating their journey towards a personal cause or in memory of a loved one.
This isn't Dr. J's first foray into global philanthropic efforts. Dr. J frequently volunteers overseas, performing procedures to correct cleft lip, cleft palate, scarring from burns and other sources, and polydactyly. In each case, Dr. J puts forth the same skill and artistry utilized in his domestic aesthetic procedures like rhinoplasty and mommy makeover in Beverly Hills. One particularly unforgettable event happened last year; a toddler was attacked by a wild dog in Peru and the timing was just right so that Dr. J was able to reconstruct the damage done to the boy's face. It's very lucky that Dr. J was still in the hospital; procedures like these often require world-class plastic surgery skills, as the delicate configuration of the face needs a practiced touch from a surgeon well-studied in facial reconstruction.
More information about Dr. J's humanitarian endeavorsand his skill as a plastic surgeon in Los Angelescan be found online at http://www.drjplasticsurgery.com. A free consultation can also be arranged with Dr. J by calling 310-228-3151.
PR submitted by http://www.Cyberset.com
See the article here:
Dr. J Sponsors Real Medicine Foundation's Presence at the 2013 LA Marathon
Duke Students Show Keen Interest in Family Medicine
I am always impressed with the passion of medicalstudents and family medicine residents, and my recent trip to DukeUniversity was no exception.
Duke's Family Medicine Interest Group (FMIG) invited me to be a speaker at their annual awards meeting in Durham, N.C. This created an opportunity for me to meet with the school's chair of community and family medicine, Lloyd Michener, M.D., (who recently made news for his work on integrating primary care and public health) and to spend some time with family medicine residents.
This trip, however, was primarily about students. There was a great deal of excitement and enthusiasm about this years Match and what it may mean for Duke's future. The school had four students match into family medicine residencies, including one who will be staying on at Duke.
Although four may not sound like a big number, it doubled last year's total and matched the school's highest number of students matching into family medicine residencies during the past six years. (For some perspective, Duke produced zero family medicine residents out of a class of 112 students in 2009.)
The students asked good questions about ways to stimulate interest in family medicine and invigorate their FMIG. We talked extensively about leadership opportunities at the AAFP's National Conference of Family Medicine Residents and Medical Students,which is scheduled for Aug. 1-3 in Kansas City, Mo., and how this can extend to students regardless of career choice. However, once students come and participate in this event, it is hard not to get excited about family medicine.
We also talked about ways of handling the usual challenges students face in family medicine. Even early in their careers, students are hearing the usual refrain of "You are too smart to go into family medicine" from their faculty and peers. This is a very real issue for our students, and it is difficult to withstand over time.
We talked about one way of reframing the situation, which is to recognize that family medicine is the largest specialty. Second, most folks who go into internal medicine, for example, subspecialize. Another way of looking at that choice would be to talk about becoming a limited practice specialist. This allows an opportunity for students interested in family medicine to say how they truly don't want to limit themselves. They want the excitement and the challenge of doing more than "just" being an orthopedist. And they could praise their peers who recognize that they need to limit their options by subspecializing. It is good to know ones boundaries.
Most important, however, is a message that we all need to hear -- not just the students. What we have been doing for many years is critical to the creation of a true health care system in this country. It has been, and continues to, be difficult at times. People don't always understand what we do. However, for the first time, people in power are talking about primary care and the patient-centered medical home. Even if they don't fully understand what those terms mean, it is a start.
Winston Churchill once said, "You can always count on Americans to do the right thing -- after they've tried everything else." We are getting to the point where our country has tried everything else to create a health care system instead of a disease-management process.
Read more from the original source:
Medicine Ball Workout - Burn Fat and Build Muscle
Medicine Ball Workout to help burn fat and build lean muscle. Medicine Ball Metabolic workout from Funk Roberts. Connect with Funk Roberts Website (Main): ht...
By: Funk Roberts
Read the original post: